10-Q: Hawkins Reports Strong Sales Growth Amid Acquisition Costs

Hawkins, Inc. reported a 14% increase in sales for the quarter and six months ended September 28, 2025, driven by strategic acquisitions, though net income and EPS declined due to higher operating and interest expenses.

Summary

• Sales for the three months ended September 28, 2025, increased by $33.4 million, or 14%, to $280.4 million compared to the prior year.
• Sales for the six months ended September 28, 2025, increased by $70.8 million, or 14%, to $573.7 million compared to the prior year.
• Net income for the three months decreased by 6.3% to $22.6 million, and for the six months decreased by 2.3% to $51.8 million.
• Diluted earnings per share (EPS) for the three months was $1.08, down from $1.16, and for the six months was $2.48, down from $2.54.
• Gross profit increased by 12% to $67.6 million for the three months and to $140.0 million for the six months.
• Selling, general and administrative (SG&A) expenses increased significantly by 27% to $33.7 million for the three months and by 26% to $64.7 million for the six months, largely due to acquisition-related costs.
• Interest expense, net, rose substantially to $3.8 million for the three months and $7.1 million for the six months, primarily due to increased borrowings for acquisitions.
• The company completed five acquisitions in the first half of fiscal 2026, including WaterSurplus, Inc. for an initial $149.9 million, contributing to $162.5 million in total acquisition spending.
• A segment realignment was effective beginning Q1 fiscal 2026, organizing the business into Water Treatment, Food & Health Sciences, and Industrial Solutions, reflecting a shift towards specialty ingredients.
• Cash and cash equivalents increased to $10.4 million at September 28, 2025, from $5.1 million at March 30, 2025.

Sentiment

Score: 6

Explanation: While the company demonstrates strong top-line growth driven by strategic acquisitions and a positive shift towards specialty ingredients, profitability metrics like net income and EPS have declined due to significantly higher SG&A expenses (including acquisition-related amortization and earnout accretion) and increased interest expense from debt financing. The long-term strategy appears sound, but short-term financial performance shows pressure from integration and financing costs.

Positives

• Strong top-line growth with sales increasing 14% for both the three and six-month periods, demonstrating effective market expansion.
• Water Treatment segment sales grew by 21% for the quarter and 24% for the six months, significantly boosted by acquired businesses and organic growth.
• Successful execution of strategic acquisitions, including WaterSurplus, Inc., which added $23 million in sales for the quarter and $52 million for the six months.
• Net cash provided by operating activities increased to $71.0 million for the six months, up from $59.2 million in the prior year, driven by favorable changes in trade receivables.
• Increased cash dividends declared per common share to $0.19 for the quarter and $0.37 for the six months, indicating confidence in future cash flows.
• The company remains in compliance with all covenants of its Credit Agreement as of September 28, 2025.

Negatives

• Net income decreased by 6.3% for the three months and 2.3% for the six months, despite significant sales growth.
• Diluted earnings per share (EPS) decreased to $1.08 for the three months and $2.48 for the six months.
• Selling, general and administrative (SG&A) expenses increased substantially by 27% for the quarter and 26% for the six months, outpacing sales growth.
• Interest expense, net, more than doubled for both the three and six-month periods due to increased debt for acquisitions.
• Gross profit margin slightly decreased from 24.4% to 24.1% for the three months and from 24.8% to 24.4% for the six months.
• Food & Health Sciences segment experienced a 4% decrease in gross profit for the three months and a 3% decrease for the six months, primarily due to lower selling prices from competitive pressures.

Risks

• Exposure to the cyclical nature of commodity chemical prices, with no forward contracts or hedging activities for purchases, meaning price increases may not always be passed to customers.
• Market risks related to interest rates, particularly on variable-rate borrowings under the Revolving Loan Facility, despite an interest rate swap for a portion of the debt.
• Uncertainties in assessing environmental claims, with a $7.7 million liability recorded for PCB remediation at the Rosemount, MN facility, and potential for additional future expenses if unknown issues arise.
• Acquisition integration risks, including the challenge of realizing anticipated synergies and managing increased operational complexities and costs associated with newly acquired businesses.
• Reliance on estimates and assumptions in financial reporting, particularly for receivables, inventories, goodwill, intangibles, and earnout liabilities, which could differ from actual results.

Future Outlook

The company expects its effective income tax rate for the full year to be approximately 26% to 27%. Management anticipates that current cash balances, available funds under the credit facility, and cash flows from operations will be sufficient to meet ongoing operational cash requirements for the foreseeable future. The company plans to continue pursuing acquisitions or other strategic relationships to complement or expand existing businesses and customer base, and may borrow additional funds or sell equity for strategic reasons or to strengthen its financial position.

Management Comments

• We realigned our reporting segments to reflect organizational changes and how we manage operations and allocate resources, believing this better reflects the value we provide and our evolution into a specialty ingredients company.
• We focus on operating income when evaluating financial results, as sales dollars tend to fluctuate with raw material prices.
• The year-over-year increase in cash provided by operating activities was primarily driven by favorable year-over-year changes in trade receivables.

Industry Context

The company's strategic realignment into Water Treatment, Food & Health Sciences, and Industrial Solutions segments, coupled with a focus on specialty ingredients over bulk commodities, indicates a move towards higher-value, more differentiated product offerings. This shift aligns with broader industry trends where companies seek to enhance margins and reduce exposure to volatile commodity markets by providing specialized solutions and services. The aggressive acquisition strategy, particularly in Water Treatment, suggests a consolidation play to expand market share and product capabilities in key growth areas.

Corporate Governance

Legal Proceedings

• No material pending legal proceedings other than ordinary routine litigation incidental to the business.

Stakeholder Impact

• Shareholders: Experience diluted EPS and lower net income in the short term due to acquisition-related costs and increased debt, but benefit from increased dividends and potential long-term growth from strategic acquisitions and segment realignment.
• Employees: Impacted by organizational changes due to segment realignment and potential integration of new employees from acquisitions, with some WaterSurplus employees receiving restricted stock awards as incentives.
• Customers: Benefit from expanded product offerings and solutions, particularly in water treatment and specialty ingredients, through recent acquisitions.
• Creditors: Increased exposure due to higher long-term debt, but the company remains in compliance with all credit facility covenants.

Next Steps

• Continue to pursue acquisitions or other strategic relationships to complement or expand existing businesses or increase customer base.
• Manage the integration of recent acquisitions, including WaterSurplus, StillWaters, MakWood lactate business, PhillTech, and Hendrickson.
• Monitor and manage the $7.7 million environmental remediation liability at the Rosemount, MN facility.
• Evaluate the impact of new accounting standards (ASU No. 2023-09 and ASU No. 2024-03) on future financial statement disclosures.
• Potentially borrow additional funds or sell equity for strategic reasons or to strengthen financial position.

Key Dates

Recommendation

Hawkins, Inc. is executing an aggressive growth strategy through acquisitions and a strategic shift towards specialty ingredients, which is reflected in strong top-line revenue growth. However, this growth comes at a significant cost, leading to a decline in net income and EPS due to increased SG&A expenses (including amortization of intangibles and earnout accretion) and substantially higher interest expenses from acquisition financing. While the long-term strategic direction appears sound and aims for higher-margin businesses, the immediate financial impact on profitability warrants caution. A 'hold' recommendation allows investors to observe the successful integration of recent acquisitions and the realization of anticipated synergies, which are crucial for translating revenue growth into improved bottom-line performance, before committing further capital.

Keywords

Specialty Chemicals, Water Treatment, Food & Health Sciences, Industrial Solutions, Acquisitions, SEC Filing, Quarterly Report, Financial Results, Earnings, Revenue Growth, Debt, Goodwill, Intangible Assets, Environmental Remediation